Bone Biologics Co. (OTC:BBLG – Get Free Report)’s share price was up 1.2% on Wednesday . The company traded as high as $0.86 and last traded at $0.85. Approximately 11,510 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 229,751 shares. The stock had previously closed at $0.84.
Bone Biologics Trading Up 1.2 %
The firm’s 50 day simple moving average is $1.00 and its 200-day simple moving average is $1.28. The stock has a market capitalization of $2.76 million, a price-to-earnings ratio of -0.02 and a beta of 0.56.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Recommended Stories
- Five stocks we like better than Bone Biologics
- Consumer Discretionary Stocks Explained
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- What is Forex and How Does it Work?
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Most Volatile Stocks, What Investors Need to Know
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
